PHARIA HEALTH

Printed materials, namely, treatment manuals and instructional and teaching materials in the field of treatments and interventions for substance use disorders, addictions, and other mental health conditions, including for the use of drug-assisted therapy in an integrated care model with psychotherapy and community support, including with approved psychedelic therapeutics; Business services, namely, establishing, operating, and managing medical clinics, facilities, and practices offering treatments and interventions for substance use disorders, addictions, and other mental health conditions, including using drug-assisted therapy in an integrated care model with psychotherapy and community support, including with approved psychedelic therapeutics; Educational services, namely, conducting classes, seminars, workshops, and training programs, and providing instructional and teaching materials including printed materials and audio and video recordings, in the field of treatments and interventions for substance use disorders, addictions, and other mental health conditions, including for the use of drug-assisted therapy in an integrated care model with psychotherapy and community support, including with approved psychedelic therapeutics; Medical and scientific research services, namely, conducting clinical trials and operating and managing clinical trial sites for drug developers of therapeutics, including psychedelic therapeutics; Medical services, namely, providing treatments and interventions for substance use disorders, addictions, and other mental health conditions, including using drug-assisted therapy in an integrated care model with psychotherapy and community support, including with approved psychedelic therapeutics; developing, customizing, and providing treatment programs for substance use disorders, addictions, and other mental health conditions, including for the use of drug-assisted therapy in an integrated care model with psychotherapy and community support, including with approved psychedelic therapeutics